Cancer BiologyEBioMedicinePeer-reviewed
A personalized medicine approach identifies enasidenib as an efficient treatment for IDH2 mutant chondrosarcoma
Verónica Rey, Juan Tornín, Juan José Alba‐Linares…·René Rodríguez
This study identifies enasidenib as an effective treatment for IDH2 mutant chondrosarcoma through personalized medicine approaches involving sequencing, cell line models, and in vitro/in vivo testing.
19 citationstop 2%